Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment

Frontiers in Immunology

Immunology

Kristian Pietras¹  Arne Östman²  Bruno Gomes³  Jehad Charo⁴ 

[1] Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University Cancer Centre, Lund University, Lund, Sweden;Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Basel, Switzerland;Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Zurich, F. Hoffmann-La Roche AG, Zurich, Switzerland;

关键词: biomarkers;    cancer;    immunotherapy;    imaging;    fibroblasts;    tumor microenvironment;    immune oncology;    checkpoint blockade;   

DOI  :  10.3389/fimmu.2023.1283186

 received in 2023-08-25, accepted in 2023-09-01,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Charo, Gomes, Pietras and Östman